BCR-ABL/ABL RATIO INCREASE THAT CORRESPONDS TOPRESENCEOFBCR-ABL MUTATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED BY IMATINIB

被引：0

作者：

Tsaur, G. ^{[1
]}

Ivanova, A. ^{[1
]}

Popov, A. ^{[1
]}

Yakovleva, Y. ^{[1
]}

Riger, T. ^{[1
]}

Ivanets, Y. ^{[2
]}

Misyurin, A. ^{[3
]}

Suchkova, M. ^{[3
]}

Shorikov, E. ^{[1
]}

Saveliev, L. ^{[4
]}

Fechina, L. ^{[1
]}

机构：

[1] Reg Childrens Hosp, Res Inst Med Cell Technol, Pediat Oncol & Hematol Ctr, Ekaterinburg, Russia

[2] Novartis Pharmaceut, BU Oncol, Ekaterinburg, Russia

[3] Minist Publ Hlth Russia, Hematol Res Ctr, Lab Gene Engn, Moscow, Russia

[4] Ural State Med Acad, Chair Lab Med, Ekaterinburg, Russia

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：S490 / S490

页数：1

共 50 条

[41] Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia
Radich, Jerald P.
CANCER, 2012, 118 (02) : 300 - 311
[42] BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Loscocco, Federica
Visani, Giuseppe
Galimberti, Sara
Curti, Antonio
Isidori, Alessandro
FRONTIERS IN ONCOLOGY, 2019, 9
[43] INHIBITION OF APOPTOSIS BY BCR-ABL IN CHRONIC MYELOID-LEUKEMIA
BEDI, A
ZEHNBAUER, BA
BARBER, JP
SHARKIS, SJ
JONES, RJ
BLOOD, 1994, 83 (08) : 2038 - 2044
[44] Quantitative detection of bcr-abl transcripts in chronic myeloid leukemia
Menif, S.
Zarrouki, S.
Jeddi, R.
ben Alaya, N.
Ali, Z. BelHadj
Ben Abid, H.
Hdeiji, S.
Elloumi, M.
Khlif, A.
Meddeb, B.
Dellagi, K.
PATHOLOGIE BIOLOGIE, 2009, 57 (05): : 388 - 391
[45] BCR-ABL mutations in chronic myeloid leukemia - Not only detection
Polakova, Katerina Machova
Zmekova, Vaclava
Rulcova, Jana
Klamova, Hana
Zemanova, Zuzana
Moravcova, Jana
LEUKEMIA & LYMPHOMA, 2008, 49 (08) : 1620 - 1622
[46] BCR-ABL targeted therapy in chronic myeloid leukemia (CML).
Goldman, JM
Deininger, M
Melo, JV
EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 515 - 515
[47] BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia
Panuzzo, Cristina
Crivellaro, Sabrina
Carra, Giovanna
Guerrasio, Angelo
Saglio, Giuseppe
Morotti, Alessandro
PLOS ONE, 2014, 9 (10):
[48] BCR-ABL ANTISENSE PURGING IN CHRONIC MYELOID-LEUKEMIA
KIRKLAND, MA
OBRIEN, SG
MCDONALD, C
DAVIDSON, RJ
CROSS, NCP
GOLDMAN, JM
LANCET, 1993, 342 (8871): : 614 - 614
[49] IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB
Tiribelli, M.
Latagliata, R.
Breccia, M.
Luciano, L.
Castagnetti, F.
Gozzini, A.
Cambrin, G. Rege
Annunziata, M.
Stagno, F.
Pregno, P.
Albano, F.
Abruzzese, F.
Musto, P.
Sora, F.
Ferrero, D.
Montefusco, E.
Cavazzini, F.
Binotto, G.
Fanin, R.
Pane, F.
Rosti, G.
Santini, V.
Fava, C.
Alimena, G.
Vigneri, P.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 347 - 347
[50] Detection of BCR-ABL point mutations in patients with chronic myeloid leukemia (CML) resistant to imatinib.
Silveira, Rosana A.
Albuquerque, Dulcineia M.
Assis, Angela M.
Ichihara, Edson
de Souza, Carmino A.
Costa, Fernando F.
Delamain, Marcia T.
Vigorito, Afonso C.
Lorand-Metze, Irene
Miranda, Eliana
Pagnano, Katia B. B.
BLOOD, 2006, 108 (11) : 289B - 289B

← 1 2 3 4 5 →